Wearable digital device for personal health use for saliva, urine, and blood testing and mobile wrist watch powered by user body

ABSTRACT

Provided are a wearable personal digital device and related methods. The wearable personal digital device may comprise a processor, a display, biometric sensors, activity tracking sensors, a memory unit, a communication circuit, a housing, an input unit, a projector, a timepiece unit, a haptic touch control actuator, and a band. The processor may be operable to receive data from an external device, provide a notification to a user based on the data, receive a user input, and perform a command selected based on the user input. The communication circuit may be communicatively coupled to the processor and operable to connect to a wireless network and communicate with the external device. The housing may be adapted to enclose the components of the wearable personal digital device. The band may be adapted to attach to the housing and secure the wearable personal digital device on a user body.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation-in-part of U.S. patent applicationSer. No. 16/126,548, entitled “WEARABLE DIGITAL DEVICE FOR PERSONALHEALTH USE FOR SALIVA, URINE, AND BLOOD TESTING AND MOBILE WRIST WATCHPOWERED BY USER BODY”, filed on Sep. 10, 2018, which is acontinuation-in-part of U.S. patent application Ser. No. 15/632,737,entitled “WEARABLE PERSONAL DIGITAL DEVICE FOR FACILITATING MOBILEDEVICE PAYMENTS AND PERSONAL USE”, filed on Jun. 26, 2017, which is acontinuation-in-part of U.S. patent application Ser. No. 15/439,276,entitled “WEARABLE PERSONAL DIGITAL DEVICE FOR FACILITATING MOBILEDEVICE PAYMENTS AND PERSONAL USE”, filed on Feb. 22, 2017, U.S. patentapplication Ser. No. 14/695,256, entitled “WEARABLE PERSONAL DIGITALDEVICE FOR FACILITATING MOBILE DEVICE PAYMENTS AND PERSONAL USE”, filedon Apr. 24, 2015, U.S. patent application Ser. No. 15/343,227, entitled“SYSTEMS AND METHODS FOR MOBILE APPLICATION, WEARABLE APPLICATION,TRANSACTIONAL MESSAGING, CALLING, DIGITAL MULTIMEDIA CAPTURE AND PAYMENTTRANSACTIONS”, filed on Nov. 4, 2016, U.S. patent application Ser. No.15/345,349, entitled “SYSTEMS AND METHODS FOR MESSAGING, CALLING,DIGITAL MULTIMEDIA CAPTURE AND PAYMENT TRANSACTIONS”, filed on Nov. 7,2016; which is a continuation-in-part of U.S. patent application Ser.No. 14/957,644, entitled “SYSTEMS AND METHODS FOR MOBILE APPLICATION,WEARABLE APPLICATION, TRANSACTIONAL MESSAGING, CALLING, DIGITALMULTIMEDIA CAPTURE AND PAYMENT TRANSACTIONS”, filed on Dec. 3, 2015,which is a continuation-in-part of U.S. patent application Ser. No.14/815,988, entitled “SYSTEMS AND METHODS FOR MOBILE APPLICATION,WEARABLE APPLICATION, TRANSACTIONAL MESSAGING, CALLING, DIGITALMULTIMEDIA CAPTURE AND PAYMENT TRANSACTIONS”, filed on Aug. 1, 2015,which claims priority to U.S. patent application Ser. No. 13/760,214,entitled “WEARABLE PERSONAL DIGITAL DEVICE FOR FACILITATING MOBILEDEVICE PAYMENTS AND PERSONAL USE”, filed on Feb. 6, 2013, which is acontinuation-in-part of U.S. patent application Ser. No. 10/677,098,entitled “EFFICIENT TRANSACTIONAL MESSAGING BETWEEN LOOSELY COUPLEDCLIENT AND SERVER OVER MULTIPLE INTERMITTENT NETWORKS WITH POLICY BASEDROUTING”, filed on Sep. 30, 2003, which claims priority to ProvisionalApplication No. 60/415,546, entitled “DATA PROCESSING SYSTEM”, filed onOct. 1, 2002, which are incorporated herein by reference in theirentirety.

FIELD

This application relates generally to personal mobile devices and, morespecifically, to wearable personal digital devices for facilitatingmobile device payments and personal use.

BACKGROUND

Mobile devices gain growing importance in daily activities of theirusers with more and more functions being performed by mobile devices.Some of such functions may include mobile communication, mobilepayments, health monitoring, and so forth. In addition to that, carryinga mobile phone, a tablet personal computer, or a laptop may not alwaysbe comfortable, for example, during physical activity or leisure time.For such purposes, wearable mobile devices, e.g. wristwatch digitaldevices, may be used. However, use of the wearable mobile devices may beinconvenient because of limited software functionality of such devices.

Furthermore, a wristwatch digital device may be communicatively coupledto a smartphone and display notifications related to smartphoneactivity, e.g. an incoming call or a message. However, a user may beunable to respond to the notification directly using the wristwatchdigital device.

SUMMARY

This summary is provided to introduce a selection of concepts in asimplified form that are further described below in the DetailedDescription. This summary is not intended to identify key features oressential features of the claimed subject matter, nor is it intended tobe used as an aid in determining the scope of the claimed subjectmatter.

Provided are An Artificial Intelligence (AI) wearable personal digitaldevice for facilitating mobile device payments, personal use, healthcare, AI wearable electrowave medical (AIWEM) device, point ofhealthcare (POH) testing, personal living T-cells drug (PLTCD), organictetranectin natural native proteins (OTNNP), the AIWEM device and POHtesting combined with PLTCD and OTNNP 3D personal healthcare and amethod for facilitating user interaction with a wearable personaldigital device for facilitating mobile device payments, personal use,and health care. The wearable personal digital device may comprise aprocessor, a near field communication (NFC) unit, a display, one or morebiometric sensors, one or more electrodes, one or more activity trackingsensors, a memory unit, a communication circuit, a housing, an inputunit, a band, a point of healthcare (POH) saliva testing, a thermalinfrared (IR) measurement of sensor, an AC electric zone, an electricalstimulus, an engineered T-cell, an engineered DNA molecule, an adhesivesensor system, a haptic touch control actuator, a battery, a set ofelectrodes with electric wires. The processor may be operable to receivedata from an external device, provide a notification to a user based onthe data, receive a user input, and perform a command selected based onthe user input. The near field communication (NFC) unit may becommunicatively coupled to the processor. The user input may be receivedthrough the display (e.g., a touchscreen) or the input unitcommunicatively coupled to the processor. The input unit may extend fromthe housing and be configured to perform one or more of a rotationalmotion and a linear motion. A thin-film sensor made of nanoparticles andpolymers, which when pressed against the skin may create changes inelectrical current and light (ECL) that can be captured by ahigh-quality digital camera of wearable device, which may detect tumorsas small as 3 millimeters, hidden up to 2-50 millimeters deep in humanbody, an electrometric radiation that human body emit when theirtemperature is above the absolute zero, the thermal infrared (IR) sensorrange may extend to cover wavelengths from 800 nanometer to few hundredmicrometer to detect Cancer using Temperature Variation and RadiationAnalysis (TVRA) via wearable computer device, which has grown tangiblydue to many factors, such as life expectancies increase, personal habitsand ultraviolet radiation exposures among others. The biometric sensorsmay be operable to sense one or more biometric parameters of the userwhich can be provided via the display, stored to the memory unit,transmitted to the external device, and so forth. The one or moreactivity tracking sensors may be communicatively coupled to theprocessor. The communication circuit may be communicatively coupled tothe processor and operable to connect to a wireless network andcommunicate with the external device. The housing may be adapted toenclose at least the processor, the display, the one or more biometricsensors, the electrodes, the one or more activity tracking sensors, thememory unit, and the communication circuit. The band may be adapted toattach to the housing and to secure the device on a user body. The pointof healthcare (POH) saliva testing may test fatal diseases includingcancer. The AC electric zone may include a field operable to killtargeted zone cancer cells and Parkinson's disease. The electricalstimulus may treat for major depressive disorder, mania, and catatonia.The engineered T-cell may to grow and expand number of T-cells in humanbody to harness the power of user's own immune system to effectivelytarget and kill cancer cells. The engineered DNA molecule may guide oneor more DNA molecules to RNA Gerba. The adhesive sensor system may beworn on a skin of the user body may automatically detect human falls andfatal diseases. The sensor may consist of a tri-axial accelerometer, amicrocontroller and a Bluetooth Low Energy transceiver. The battery maybe disposed in the housing of the wearable personal digital device.

In some embodiments, the wearable personal digital device forfacilitating mobile device payments, personal use, and health care mayfurther include a camera communicatively coupled to the processor. Thecamera may be operable to capture a code, the codes including one ormore of the following: a linear dimensional code, a two-dimensionalcode, a snap tag code, and a Quick Response code. The code may be readby the processor to obtain one or more of product information andmerchant information encoded in the code, and initiate a paymenttransaction based on the merchant information.

Furthermore, the display may be operable to be activated based on one ormore of the following: a movement of a user hand, a movement of the userbody, a gesture performed by the user in proximity to the display, and auser voice. Additionally, the display may display data associated withthe activity of the user, such as calories burned, sleep quality,breaths per minute, snoring breaks, steps walked, distance walked, andso forth.

In further exemplary embodiments, modules, subsystems, or devices can beadapted to perform the recited steps. Other features and exemplaryembodiments are described below.

BRIEF DESCRIPTION OF DRAWINGS

Embodiments are illustrated by way of example and not limitation in thefigures of the accompanying drawings, in which like references indicatesimilar elements and in which:

FIG. 1 illustrates an environment within which the wearable personaldigital device for facilitating mobile device payments, personal use,and health care and methods for facilitating user interaction with thewearable personal digital device for facilitating mobile device paymentsand personal use can be implemented, in accordance with someembodiments.

FIG. 2 illustrates an example wearable personal digital device forfacilitating mobile device payments, personal use, and health care, inaccordance with some embodiments.

FIG. 3 illustrates an example of a wearable personal digital device forfacilitating mobile device payments, personal use, and health carescannable by a Point-of-Sale system, in accordance with someembodiments.

FIG. 4 shows user interaction with a display of a wearable personaldigital device for facilitating mobile device payments, personal use,and health care, in accordance with some embodiments

FIG. 5 is a flow chart illustrating a method for facilitating userinteraction with a wearable personal digital device for facilitatingmobile device payments, personal use, and health care, in accordancewith certain embodiments.

FIG. 6 illustrates an example of wearable personal digital devices forfacilitating mobile device payments, personal use, and health care, inaccordance with some embodiments.

FIG. 7 illustrates an example of wearable personal digital devices forfacilitating mobile device payments, personal use, and health care, inaccordance with some embodiments.

FIG. 8 illustrates an example of wearable personal digital devices forfacilitating mobile device payments, personal use, and health care, inaccordance with some embodiments.

FIG. 9 illustrates an example of wearable personal digital devices forfacilitating mobile device payments, personal use, and health care, inaccordance with some embodiments.

FIG. 10 shows a point of healthcare saliva testing device for point ofhealthcare saliva testing being a component of an artificialintelligence wearable and mobile personal digital device forfacilitating mobile device payments, personal saliva testing, personaluse, and health care, according to an example embodiment.

FIG. 11 shows a point of healthcare saliva testing device for point ofhealthcare saliva testing being a component of an artificialintelligence wearable and mobile personal digital device forfacilitating mobile device payments, personal saliva testing, personaluse, and health care, according to an example embodiment.

FIG. 12 shows a right side view of the point of healthcare salivatesting device, a left side view of the point of healthcare salivatesting device, a front view of the point of healthcare saliva testingdevice, and a rear view of the point of healthcare saliva testingdevice, according to an example embodiment.

FIG. 13 shows a top view of the point of healthcare saliva testingdevice and a bottom view of the point of healthcare saliva testingdevice, according to an example embodiment.

FIG. 14 shows a general view of an artificial intelligence wearable andmobile personal digital device with a POH saliva testing device forpoint of healthcare saliva testing, according to an example embodiment.

FIG. 15A and FIG. 15B illustrate systems for performingelectroconvulsive therapy (ECT), in accordance with some embodiments.

FIG. 16 illustrates a healthcare method for a cancer treatment, inaccordance with some embodiments.

FIG. 17 illustrates stages of progress of cancerous diseases.

FIG. 18 is a schematic diagram of an artificial intelligence wearabledigital device having a thermoelectric generator, according to anexample embodiment.

FIG. 19 shows a schematic diagram of a heat-to-electricity conversion,according to an example embodiment.

DETAILED DESCRIPTION

In the following description, numerous specific details are set forth inorder to provide a thorough understanding of the presented concepts. Thepresented concepts may be practiced without some or all of thesespecific details. In other instances, well known process operations havenot been described in detail so as to not unnecessarily obscure thedescribed concepts. While some concepts will be described in conjunctionwith the specific embodiments, it will be understood that theseembodiments are not intended to be limiting.

A wearable personal digital (WPD) device for facilitating mobile devicepayments, personal use, and health care and related methods aredescribed herein. The WPD device may include a housing enclosing allcomponents of the WPD device and a band attached to the housing.Furthermore, the WPD device may perform a function of a health andactivity monitor. More specifically, the WPD device may sense biometricdata associated with the user (blood pressure, heart rate, temperature,and so forth) using biometric sensors and/or receive data on usermovements using accelerometers or a Global Positioning System (GPS)unit. Biometric data and user movement data may be shown on a display ofthe WPD device, stored in a memory unit of the WPD device, and/orprocessed by a processor of the WPD device to produce historical oraveraged data.

The WPD device may be communicatively coupled with an external device,such as a smartphone. The WPD device and the smartphone may communicateusing a wireless network, such as a Wi-Fi network or a Bluetoothnetwork. The WPD device may display notifications from the smartphone.The notifications may represent receipt of any type of data by thesmartphone, for example, a phone call, a message, an upcoming calendarevent, a social network event, and the like. A user may respond to thenotification directly via the WPD device, or using the smartphone. Thebiometric data and user movement data collected by the WPD device may besent to the smartphone for further processing.

The display of the WPD device may be represented by a touchscreen. Theuser may provide commands to the WPD device by varying the time of userinteraction with the touchscreen. More specifically, the user may varythe time of pressing the touchscreen. Different time of pressing thetouchscreen may correspond to different commands. For example, pressingthe touchscreen for 1 second may correspond to a message mode.Therefore, after the user touches the touchscreen for 1 sec and releasesa user finger from the touchscreen, the message mode may be activated.Similarly, pressing the touchscreen for 5 seconds may correspond to apayment mode. The payment mode may be performed by using scanning ofcodes. Additionally, payment cards may be read using a swipe card readeroptionally included into the WPD device.

Referring now to the drawings, FIG. 1 illustrates an environment 100within which the WPD device 200 and methods for facilitating userinteraction with the WPD device 200 can be implemented. The environment100 may include a network 110, a WPD device 200, a mobile base station120, a GSM satellite 130, and one or more external devices 140. The WPDdevice 200 may be worn by a user 150. The network 110 may include theInternet or any other network capable of communicating data betweendevices. Suitable networks may include or interface with any one or moreof, for instance, a local intranet, a Personal Area Network, a LocalArea Network, a Wide Area Network, a Metropolitan Area Network, avirtual private network, a storage area network, a frame relayconnection, an Advanced Intelligent Network connection, a synchronousoptical network connection, a digital T1, T3, E1 or E3 line, DigitalData Service connection, Digital Subscriber Line connection, an Ethernetconnection, an Integrated Services Digital Network line, a dial-up portsuch as a V.90, V.34 or V.34bis analog modem connection, a cable modem,an Asynchronous Transfer Mode connection, or an Fiber Distributed DataInterface or Copper Distributed Data Interface connection. Furthermore,communications may also include links to any of a variety of wirelessnetworks, including Wireless Application Protocol, General Packet RadioService, Global System for Mobile Communication, Code Division MultipleAccess or Time Division Multiple Access, cellular phone networks, GlobalPositioning System, cellular digital packet data, Research in Motion,Limited duplex paging network, Bluetooth radio, or an IEEE 802.11-basedradio frequency network. The network 110 can further include orinterface with any one or more of an RS-232 serial connection, anIEEE-1394 (Firewire) connection, a Fiber Channel connection, an IrDA(infrared) port, a SCSI (Small Computer Systems Interface) connection, aUniversal Serial Bus (USB) connection or other wired or wireless,digital or analog interface or connection, mesh or Digi® networking. Thenetwork 110 may be a network of data processing nodes that areinterconnected for the purpose of data communication. The WPD device 200may communicate with the GPS satellite via the network 110 to exchangedata on a geographical location of the WPD device 200. Additionally, theWPD device 200 may communicate with mobile network operators using themobile base station 120.

For the purposes of communication, the WPD device 200 may be compatiblewith one or more of the following network standards: GSM, CDMA, LTE,IMS, Universal Mobile Telecommunication System (UMTS), 4G, 5G, 6G andupper, RFID, and so forth.

FIG. 2 illustrates an example of the WPD device 200 in accordance withsome embodiments. FIG. 2 shows a front view 205 of the WPD device 200according to one example embodiment, a front view 210 of the WPD device200 according to another example embodiment, a back view 215 of the WPDdevice 200 according to an example embodiment, and a detached view 220of the WPD device 200 according to an example embodiment.

As shown on the front view 205 and the back view 215 of FIG. 2, the WPDdevice 200 may comprise a housing 202, which encloses a processor (notshown), a display 204, a memory unit (not shown) communicatively coupledto the processor, a communication circuit (not shown), biometric sensors(not shown) operable to sense one or more biometric parameters of theuser, activity tracking sensors (not shown), an input unit 206, aprojector (not shown), a timepiece unit (not shown), a haptic touchcontrol actuator (not shown), a near field communication (NFC) unit (notshown) communicatively coupled to the processor, and a band 208.

The processor may be operable to receive data from an external device(not shown). Based on the data, the processor may be operable to providea notification to a user. In an example embodiment, the notification maybe provided via one or more of the following: a vibration, a sound, alight indication, and so forth. The light indication may be generatedusing a light indicator 218. The processor may be further operable toreceive a user input provided by the user in response to reviewing thenotification. Furthermore, the processor may be operable to perform acommand for calculating hourly health data and related mobile devicespayment selected based on the user input. The processor may be furtheroperable to provide a natural language user interface to communicatewith the user. The natural language user interface may be operable tosense a user voice and provide a response in a natural language to theuser. The WPD device 200 may further include an operating system beingexecuted on the processor. The operating system may include Android,iOS, Firefox OS, and so forth.

The display 204 may be communicatively coupled to the processor. In anexample embodiment, the display 204 includes a touchscreen. The display204 may be used to receive the user input. More specifically, the usermay provide the user input by pressing the display 204, performingmovements on the display 204 (e.g. moving a finger from left to right,from up to down, and the like). In an example embodiment, the display204 includes a force sensor. The force sensor may be operable to sense atouch force applied by the user to the display 204 and calculatecoordinates of a touch by the user. The force sensor may be furtheroperable to analyze the touch force and, based on the touch force,select a tap command or a press command based on a predeterminedcriteria. The predetermined criteria may include a value of the touchforce. In an example embodiment, the display 204 may be operable to beactivated based on one or more of the following: a movement of a userhand, a movement of the user body, a gesture performed by the user inproximity to the display, a user voice, and so forth.

In a further example embodiment, the processor may be operable to detectabsence of interaction of the user with the display. The detection maybe made based on an eye tracking of the user, a head tracking of theuser, and a spatial position of the housing. Based on the detecting, theprocessor may be operable to dim the display 204. Additionally, theprocessor may be operable to activate the display 204 based on a spatialposition of the housing or a gesture of the user body, such as a userhand.

In a further example embodiment, the processor may be operable toreceive, using the natural language user interface, a map request fromthe user. In response to the map request, the processor may display viathe display 204, a map and a route depicted on the map. Additionally,the processor may be operable to provide an indication associated withthe route to the user. The indication may be provided using the hapticfeedback. The indication may include for example, providing hapticfeedback, such as a vibration, one time for a direction to the left, twotimes for the direction to the right, or any other type of feedback.

In a further example embodiment, the processor may be operable toanalyze a message received by the external device. The analyzing mayinclude one or more of the following: parsing a text; reading an image,recognizing a voice, and the like. Based on the analysis, one or morepossible replies may be displayed to the user using the display 204.Furthermore, a selection of a reply from the one or more possiblereplies may be received from the user. Based on the selection, theprocessor may be operable to send the reply to the external device.

In an example embodiment, the processor may be operable to analyze theuser activity. Based on the analyzing, one or more diagrams may bedisplayed to the user. The one or mode diagrams may represent one ormore activity types of the user.

The projector may be communicatively coupled to the processor. Theprojector may be operable to project a data onto a viewing surface. Thedata may include one or more of the following: a virtual keyboard, thenotification of the external device, time, data requested by the user, acaller name, a text message, a reminder, a social media alert, an email,a weather alert, and the like. The viewing surface may include a userarm, a user hand, and any surface in proximity to the WPD device 200. Inan example embodiment, the projector may project data to the left sideor to the right side with respect to the wrist of the user.

The timepiece unit may be communicatively coupled to the processor andconfigured to provide time data.

The communication circuit may be communicatively coupled to theprocessor and configured to connect to a wireless network andcommunicate with the external device to calculate hourly health data andmake related mobile devices payments. In an example embodiment, thecommunication circuit may include one or more of the following: awireless transceiver, a Bluetooth module, a Wi-Fi module, acommunication port, and the like. The communication port may include oneor more of the following: a USB port, a parallel port, an infraredtransceiver port, a radiofrequency transceiver port, and so forth.

The input unit 206 may be communicatively coupled to the processor. Inan example embodiment, the input unit 206 may extend from the housing202 and may be configured to perform a rotational motion and a linearmotion. One or more motions may be operable to input commands to theprocessor. Therefore, the input unit 206 may be rotated around alongitudinal axis of the input unit 206, may be pushed into the housing202, or may be extended from the housing 202. Thus, the input unit 206may be operable to receive the user input.

The band 208 may be adapted to attach to the housing 202 and to securethe WPD device 200 on a user body or clothes of the user. In variousembodiments, the WPD device 200 may be secured on a wrist, an arm, aneck, a head, a leg, a waist, an ear, a finger, or any other part of thehuman body, or on any part of the clothes of the user. The band 208 maybe adapted to secure the WPD device 200 under, within or on the clothesof the user. The band 208 may be an expansion bracelet, one piece band,two piece band, and so forth. In some embodiments, the band 208 mayinclude a clasp adapted to fix the band 208 in a specific position tosecure the WPD device 200 around the wrist.

In an example embodiment, the WPD device 200 may further include acamera 212. The camera 212 may be configured to capture a code, such asa linear dimensional code, a two-dimensional code, a snap tag code, anda Quick Response (QR) code. Upon capturing the code by the camera 212,the processor may be operable to read the captured code to obtainproduct information or merchant information encoded in the code. Morespecifically, the user may capture barcodes of products provided in astore. Upon reading the barcode, product information may be provided tothe user on the display 204. In an example embodiment, the productinformation may be displayed on the external device, such as asmartphone. Additionally, the merchant information may be retrieved fromthe barcode. The merchant information may include merchant paymentinformation. Upon obtaining product information and merchantinformation, the processor may initiate a payment transaction based onthe merchant information. During the payment transaction, an amount ofmoney corresponding to a price of the product may be transferred from auser payment account to a merchant payment account. The price of theproduct may be included into the product information. The paymenttransaction may be performed by sending payment data by an NFC unit ofthe WPD device to a merchant using an NFC.

In an example embodiment, the NFC may be used for payments for purchasesmade online and offline. A user of the WPD device 200 equipped with theNFC unit may perform transactions without authentication, or someauthentication may be needed, such as a Personal Identification Number(PIN), before transaction is completed. The payment can be deducted froma pre-paid account of the user or charged directly to a bank account ofthe user. In example embodiment, the NFC unit may enable the WPD device200 to establish radio communication with external devices by touchingthe WPD device 200 and the external device together or bringing theminto proximity.

In an example embodiment, the camera 212 may be further operable totrack a face, fingers, gestures, and other biometric personal data ofthe user. In turn, the processor may be operable to analyze the face,the fingers, the gestures, and the other biometric personal data trackedby the camera. Additionally, the processor may recognize speech andsubtract a background noise from the speech.

The camera 212 may be further operable to perform an optical characterrecognition of a data. The data may include one or more of thefollowing: a typewritten text, a printed text, an image, and the like.The data may be scanned from a document, such as a passport, an invoice,a bank statement, a computerized receipt, a business card, a mail, aprintout of static-data, a book, a print publication, and so forth.

In a further example embodiment, the WPD device 200 may be adapted todisplay a unique code to be scanned by a Point-of-Sale (POS) system.FIG. 3 shows a schematic representation 300 of scanning a barcode 305displayed on the WPD device 200 by a barcode scanner 310 of the POSsystem 315. The barcode 305 may encode user payment information, such asa bank account, a payment card number, and so forth. The barcode 305 maybe generated by a payment system (not shown) associated with the WPDdevice 200 or the external device. Therefore, the user may use thebarcode 305 instead of a debit card or a credit card.

Referring back to FIG. 2, the front view 210 of the WPD device 200 showsan example embodiment, according to which the WPD device 200 includes aswipe card reader 214 communicatively coupled to the processor. Theswipe card reader 214 may be located on either side of the WPD device200, vertically or horizontally. The swipe card reader 214 may beoperable to read data of a payment card. Upon reading, the data may betransmitted to the processor of the WPD device 200 or to the externaldevice. The swipe card reader 214 may be used, for example, duringperforming payments on-line. Furthermore, the swipe card reader 214 maybe used for providing user payment information, which may be furtherencoded into a barcode 216. The barcode 216 may be displayed on thedisplay 204, e.g., in a store, for performing the payment transaction.

The biometric parameters sensed by the biometric sensors may be storedto the memory unit of the WPD device 200. According to anotherembodiment, the biometric parameters sensed by the biometric sensors maybe transmitted to the external device for further processing ordisplaying on the external device. The processor may be operable toprovide data associated with biometric parameters to be displayed on thedisplay 204. The biometric parameters may include one or more of thefollowing: a blood pressure, a heart rate, a glucose level, a bodytemperature, an environment temperature, arterial properties of theuser, and the like. The biometric sensors may be disposed within theband. Based on detection that the one or more of the biometricparameters of the user exceed predetermined limits, the biometricsensors may be configured to produce the alarm. In an exampleembodiment, the biometric sensors include lenses operable to useinfrared light-emitting diodes (LED) and visible-light LEDs to sense aheart rate of the user. In a further example embodiment, the biometricsensors may be operable to non-invasively monitor a glucose level. Theglucose level may be monitored using a saliva testing. Wearable devicemay be integrated with one or more thin film silicon photonic biosensorthat uses beams of light to detect tiny changes in the composition of asaliva or urine sample on the screen of wearable device or mobiledevice, which essentially looks at the level of binding between a DNAprobe and target microRNA to figure out the level of microRNA in thesample. This can then provide clues to the presence of some types ofcancer, cardiac disease, and other serious health issues via artificialintelligence (AI) big data analysis.

The biometric sensors may further include a skin contact sensor dataengine. The skin contact sensor data processing engine may be operableto monitor a user electrocardiogram or the heart rate. The userelectrocardiogram and the heart rate may serve as identification andpersonal data of the user. The skin contact sensor data processingengine may be further operable to prompt the user to enter a PIN afterplacing the WPD device 200 on the wrist. The skin contact sensor dataprocessing engine may associate the PIN with the user electrocardiogramand the heart rate. Therefore, in case of placing the WPD device 200 ona wrist of another user, another user may be not authorized to user theWPD device 200 because a user electrocardiogram and a heart rate ofanother user may differ from those of the user of the WPD device 200.

A thermal infrared (IR) measurement of sensor may be used to investigatethe potential of cancer detection. An adhesive sensor system worn on theskin that may automatically detect human falls and fatal diseases, thesensor, which may consist of a tri-axial accelerometer, amicrocontroller and a Bluetooth Low Energy transceiver, can be wornanywhere on a human body to detect a specific biological analyte byessentially converting a biological entity into an electrical signalthat can be detected and analyzed by using of biosensor in cancer andother fatal diseases detection and monitoring.

An AC electric zone may have a field strength between 1 and 12 V/cm. TheAC electric zone may have a frequency between 101 kHz and 330 kHz tokill targeted zone cancer cells and Parkinson's disease.

An electrical stimulus may be used in AI wearable electrowave medical(AIWEM) device include about 800 milliamps and up to several hundredwatts, and the current flows for between one and 8 seconds may treatmajor depressive disorder, mania, and catatonia.

An engineered T-cells with CAR or TCR gene from white blood cells aspersonal living T-cells drug (PLTCD) may grow and expand number ofT-cells in human body to harness the power of user's own immune systemto effectively target and kill cancer cells.

An engineered DNA molecule (EDNAM) for gene based diseases and geneticdisorder diseases (GDD) which encoding the gene of one or morenon-naturally existing Cas system may comprise one Cas protein and oneor more direct RNA, which may guide one or more DNA molecules to RNAGerba. The one or more directing RNA may encode the targeting one orgenomic locus DNA molecules. The various genes may encode the Casprotein cleavage of one or more DNA molecules genomic locus gene. Theexpression of one or more gene may be replaced. The Cas protein and theRNA may not be common naturally existing guidance.

The haptic touch control actuator may be operable to produce a hapticfeedback in response to one or more events. The one or more events mayinclude receiving of the alert, receiving of a notification, aconfirmation, movement of the WPD device 200, receiving of the userinput, sensing of the one or more biometric parameters, and so forth.The haptic feedback may be sensed by the user body, such as a wrist ofthe user. The haptic feedback may have a plurality of feedback types.More specifically, each of the one or more events may be associated withone of the plurality of feedback types. In a further example embodiment,the display 204 may be further operable to display data associated withthe activity of the user. The activity of the user may include caloriesburned, sleep quality, breaths per minute, snoring breaks, steps walked,distance walked and the like. The activity of the user may be tracked bythe activity tracking sensors of the WPD device 200. The activitytracking sensors may be operable to monitor user movements in athree-dimensional trajectory, identify type of user activity, identify aspecific motion fingerprint of an exercise, evaluate user physical form,count repetitions, calculate calories burned, and so forth. In certainexample embodiments, the activity tracking sensors may sense and trackposition of the user to identify the snoring of the user and provide anotification to the user, e.g. using the vibration, to force the user tochange the position. In an example embodiment, the activity trackingsensors are operable to track snoring of the user and, based on trackingof the snoring, produce an alarm to the user to break snoring.

In an example embodiment, the WPD device 200 may further include amicrophone (not shown). The microphone may be operable to sense voicedata. The voice data may be obtained from the user. For example, theuser may provide a user request using user voice. The voice data mayinclude a voice command, a voice memo, a voice message, and the like.The voice data may be transmitted to the processor for furtherprocessing. In particular, the processor may be operable to recognizethe voice data in order to obtain the user request. The user request maybe transmitted to the external device.

In an example embodiment, the input unit 206 may include a clock crownlocated on any of lateral sides of the housing, an upper side of thehousing, or a bottom side of the housing. The processor may be operableto sense the rotational motion of the input unit 206. For example, theuser may rotate the input unit 206. Based on the sensing, the datadisplayed on the display 204 may be scrolled. Each action performed bythe user on the input unit 206, such as direction of rotation (e.g.,clockwise or counter clockwise), speed of rotation, pressing the inputunit 206 towards the housing 202, or extending the input unit 206outwards the housing 202, may correspond to a specific command.

In a further example embodiment, the processor of the WPD device 200 maybe operable to control an operation of a camera of the external device.Furthermore, the processor may access audio files stored on the externaldevice and wirelessly connect with earphones. Upon accessing theexternal device and connecting with the earphones, the processor mayreproduce the audio files using the earphones. Therefore, the user ofthe WPD device 200 may listen to the music stored on the external deviceand control reproducing of the audio files using the WPD device 200.

In an example embodiment, the processor may be further operable togenerate a code encoding user payment data and user personal data. Thegeneration may be performed based on the user payment data and the userpersonal data stored in the memory unit of the WPD device 200. Theprocessor may be further operable to prompt the user to touch thedisplay to scan user fingerprints. Additionally, the processor may befurther operable to determine a heart rate of the user using thebiometric sensors. The processor may be further operable to compare theuser fingerprints and the heart rate of the user with referencefingerprints and a reference heart rate. The reference fingerprints andthe reference heart rate may be stored in the memory unit. The processormay detect a match of the user fingerprints with the referencefingerprints and of the heart rate of the user with the reference heartrate. Base of the detecting, the processor may provide the code to amerchant digital device for performing a payment transaction. Upon thepayment transaction, a payment confirmation may be provided to the user.The payment confirmation may be provided using the haptic feedback.

In an example embodiment, the processor may be further operable todetect current user location, e.g. using a GPS unit. The processor maybe operable to detect presence of premises associated with the user inproximity to the current user location. The premises may include a home,an office, a garage, a car, and the like. Based on the detecting, theprocessor may be operable to initiate unlocking of the premises.

In a further example embodiment, the processor of the WPD device 200 maybe operable to detect presence of another WPD device in proximity to theWPD device 200. Based on the detecting, the processor may be operable toinitiate data transmission between the WPD device 200 and another WPDdevice.

In an example embodiment, the processor may be further operable toreceive, from the user, a content access request for at least onecontent item of content data stored in the memory unit of the WPD device200. The processor may read access rules stored in the memory unit. Theaccess rules may be associated with use of the at least one contentitem. Based on the access rules, the processor may be operable todetermine that an access to the at least one content item is permitted.Based on the determining, the at least one content item may bereproduced to the user.

The content data may include audio data, video data, text, software, andgame data. The WPD device 200 may act as a data carrier and include aninterface for sending and receiving data. The memory unit may beoperable to store received content data, provide payment validation datato the external device, store a record of access made to the storedcontent data, and the access rules for controlling access to the storedcontent data. The processor may be further operable to access controldata and supplementary data including hot links to websites andadvertising data. Payment data, the stored content data and access rulesdata may be used to reduce a risk of an unauthorized access to thecontent data.

The WPD device 200 may further include a battery (not shown) disposed inthe housing. Additionally, the WPD device 200 may include a magneticinductive charging unit (not shown). The magnetic inductive chargingunit may be operable to magnetically connect to the housing andwirelessly connect to the battery. The magnetic inductive charging unitmay be operable to wirelessly transfer energy to the battery. In someexample embodiments, the magnetic inductive charging unit may beintegrated into the housing. Once connected magnetically to the back ofthe WPD device 200, the connection of magnetic inductive charging unitmay be seamless and need no additional alignment by the user.

The WPD device 200 may further include a set of electrodes with electricwires. The set of set of electrodes may be connected to a POH device.

The WPD device 200 may further include a light indicator operable toshow a light indication in response to receiving data from an externaldevice. Upon a predetermined movement of the user body, such as raisinga hand, the light indication may stop showing the light indication andinitiate the display to display the data received from an externaldevice.

In example embodiments, the housing may have round, square, rectangularand other shape. Therefore, when the WPD device 200 is paired with theexternal device, a plurality of applications running on the externaldevice may be visualized on the display of the WPD device 200 using aform factor specific to the form and size of the housing.

FIG. 4 shows diagrams 400 and 405 that represent user interaction withthe display 204 of the WPD device 200. The user may provide the userinput by pressing the display 204 for a predetermined time. Theprocessor may estimate time of the user input. The time of user inputmay correspond to a specific command. The memory unit may store a tablerepresenting relationship between duration of pressing and a pluralityof commands. For example, as shown on the diagram 400, the user maypress the display 204 for 1 second. The time of 1 second may correspondto a message mode. Therefore, based on the time of 1 second, theprocessor may select a command from the table, such as initiation of themessage mode. The processor may further perform the selected command,namely, initiate the message mode. During the time when the user pressesthe display 204, a timer 402 may be displayed on the display 204. Thetimer 402 may show the time the user presses the display 204.Additionally, an icon 404 may be displayed. The icon 404 may represent acommand corresponding to the time currently shown on the timer 402. Forexample, the icon 404 may represent the message mode.

In another example embodiment, as shown on the diagram 405, the user maypress the display 204 for 5 seconds. The time of 5 seconds maycorrespond to a payment mode. Therefore, based on the time of 5 second,the processor may select a command from the table, such as initiation ofthe payment mode. The timer 402 may show the time the user presses thedisplay 204, namely 5 seconds. Additionally, an icon 406 representingthe payment mode may be displayed.

Referring back to FIG. 2, the WPD device 200 may further include avibration unit (not shown) in communication with the processor. Thevibration unit may be activated in response to receiving the data fromthe external device to notify the user about receipt of the data. Forexample, upon receipt of the message by the remote device, the vibrationunit of the WPD device 200 may be activated.

In an example embodiment, the band 208 of the WPD device 200 may bedetachable. The detached view 220 shows the band 208 detached from thehousing 202 of the WPD device 200.

The WPD device 200 may further include a GPS unit (not shown) configuredto track geographical location of the device. Such information may beapplied for spatial and positional awareness tracking, monitoringposition of a child, a senior, or a patient. In some embodiments, theWPD device 200 may connect to one or more external devices (for example,other WPD devices), synchronize with the one or more external devices inreal time, tracks a geographical location of the one or more externaldevices in real time, and provide communication capabilities using anembedded emergency button configured to give a medical alert signal, arequest for help signal, or another informational signal. Thus, usersmay track geographical location of each other.

In some embodiments, access to the WPD device 200 may be protected by apassword, a Personal Identification Number code, biometricauthorization, and so forth. Biometric authorization may be performedusing one or more biometric sensors and may include fingerprintscanning, palm scanning, face scanning, retina scanning, heart ratesensing, and so forth. In some embodiments, fingerprint scanning may beperformed using a fingerprint reader integrated in the WPD device 200 ordetachably connected to the WPD device. The scanned fingerprint may bematched to one or more approved fingerprints stored in the memory unitof the WPD device 200. The access to the device may be granted if thescanned fingerprint matches one of the stored fingerprints, otherwiseaccess may be denied.

The payment transaction may be associated with an NFC and be performedfor purchases online and offline. A payment associated with the paymenttransaction may be transferred from a pre-paid account of the user orcharged to a mobile account of the user or a bank account of the user.The payment may include at least a one-touch and one-scan payment forstreet parking in demarcated areas. The payment may be performed using alicense plate, transponder tags, barcode stickers, and reading the codefrom the display. A merchant may use a combination of the NFC and thecode on the display for performing the one-touch and one-scan payment.The NFC may be used to establish radio communication with the externaldevice by touching the housing of the WPD device 200 and the externaldevice or bringing the housing of the WPD device 200 and the externaldevice into proximity, such a distance of up to 10 centimeters. Theprocessor may be operable to operate in three modes, such as an NFCtarget mode when the WPD device 200 is acting as a credential, an NFCinitiator mode when the WPD device 200 is acting as a reader, and an NFCpeer-to-peer mode. The payment may be further associated withadvertisement tags, two-dimensional barcodes, and ultra-high frequencytags. The processor may be operable to be connected to a cloud. Usercredentials may be provisioned over the air. The payment may beassociated with a payment application associated with the processor tocontrol transferring of the payment and access payment readers. The NFCunit may be operable to connect to a third-party NFC device with aserver for data.

The processor may be associated with an operating system operable topair with third-party applications running on the external device. Theprocessor may integrate a third-party developer technology and thethird-party applications and notifications into a form factor. Theprocessor may be operable to download applications. The WPD device 200may act as or be associated with smart textiles, an activity tracker, asmartwatch, smartglasses, a GPS watch, mixed reality, computer-mediatedreality, clothing technology, Smart closing, healthcare, augmenterreality, and smart and connected devices.

The WPD device 200 may be adapted to enable a Bluetooth low energypayment. The WPD device 200 may be further associated with one or moreof a transactional payment based on Unstructured Supplementary ServiceData, Short Message Service, direct operator billing, a credit cardmobile payment, an online wallet, a QR code payment, contactless NFC, acloud-based mobile payment, an audio signal-based payment, a BluetoothLow Energy signal beacon payment, an in-application payment, a SoftwareDevelopment Kit payment, an Application Programming Interface payment, asocial networking payment, and a direct carrier and bank co-operation.

FIG. 5 is a flow chart illustrating a method 500 for facilitating userinteraction with a WPD device, in accordance with certain embodiments.The method 500 may start with receiving data from an external device atoperation 502. Based on the data, a notification may be provided to auser at operation 504. In an example embodiment, providing of thenotification includes one or more of the following: providing avibration, providing a sound, and providing a light indication. Atoperation 506, a user input may be received. In an example embodiment,the user input may be received using a display, an input unit of the WPDdevice, or a natural language user interface. At operation 508, acommand may be performed. In an example embodiment, the command selectedbased on the user input may be performed. At operation 510, the WPDdevice may be connected, using a communication circuit communicativelycoupled to the processor of the WPD device, to a wireless network tocommunicate with the external device calculating hourly health data andmake related mobile devices payments.

At operation 512, the natural language user interface may be provided tocommunicate with the user. The natural language user interface may beoperable to sense a user voice and provide a response in a naturallanguage to the user. The WPD device may be secured on a user body atoperation 514 using a band attached to a housing of the WPD device.

In an example embodiment, the method 500 may further include capturing,by a camera communicatively coupled to the processor, a code. The codemay include a linear dimensional code, a two-dimensional code, a snaptag code, or a QR code. The method 500 may further include reading thecode to obtain product information and merchant information encoded inthe code. Based on the merchant information, a payment transaction maybe initiated.

Additionally, the method 500 may include activating the display based onone or more of the following: a movement of a user hand, a movement ofthe user body, a gesture performed by the user in proximity to thedisplay, user voice, and the like. In an example embodiment, the method500 further includes storing the biometric parameters sensed by the oneor more biometric sensors to the memory unit of the WPD device.Alternatively, the biometric parameters sensed by the one or morebiometric sensors may be transmitted to the external device.

Additionally, the method 500 may include sensing, by a microphone, voicedata. The voice data may be obtained from the user and may include avoice command, a voice memo, or a voice message. The voice data andpersonal health data may be transmitted to the processor of the WPDdevice for further processing. Additionally, the voice data may berecognized to obtain a user request. The user request may be transmittedto the external device.

In an example embodiment, the method 500 may further include estimatingtime of the user input. The user input may include pressing the displayby the user. Based on the time, a command may be selected from a tablerepresenting relationship between the time of pressing and a pluralityof commands. The selected command may be further performed by theprocessor.

In an example embodiment, the methods may further display dataassociated with the activity of the user, the activity of the userincluding calories burned, sleep quality, breaths per minute, snoringbreaks, steps walked, and distance walked. Tumor DNA may be used as amarker for screening, early detection, and monitoring, traces of RNAfrom cancer cells can be found in a drop of saliva, urine and blood withpoint of healthcare (POH) testing device, the RNA is a molecule thatplays a key role in the transcription of DNA, the mobile and wearabledevice screen process by which the genetic material is read in order todetect the proteins by detecting genetic mutations in a protein fromepidermal factor receptor, by examining RNA in samples on mobile andwearable screens. The processes may go on inside a cell by seeking outfragments of tumor RNA in saliva, urine and blood including thoseassociated with cancer and other fatal diseases. The thin film siliconphotonic biosensor may be operable to use beams of light to detect tinychanges in the composition of a saliva, urine or blood sample on thescreen of wearable device or mobile device with processing data frompoint of health (POH) testing. The level of binding between a DNA probeand target microRNA operable to figure out the level of microRNA in thesample. Presence of some types of cancer, cardiac disease, and otherserious health issues may be detected via artificial intelligence (AI)big data analysis. The biosensors may be operable to detect a specificbiological analyte by essentially converting a biological entity into anelectrical signal that can be detected and analyzed by using ofbiosensors in cancer detection and monitoring. The biosensors may befurther operable to detect emerging cancer biomarkers and to determinedrug effectiveness at various target sites. Furthermore, the biosensorsmay be operable to provide fast and accurate detection, reliable imagingof cancer cells, and monitoring of angiogenesis and cancer metastasis,and determine the effectiveness of anticancer chemotherapy agents.

Additionally, the method 500 may include displaying, by the display,data associated with the activity of the user. The activity of the usermay include calories burned, sleep quality, breaths per minute, snoringbreaks, steps walked, and distance walked. Tumor DNA to be used as amarker for screening, early detection, and monitoring, traces of RNAfrom cancer cells can be found in a drop of saliva, the RNA is amolecule that plays a key role in the transcription of DNA, the mobileand wearable device screen process by which the genetic material is readin order to detect the proteins by detecting genetic mutations in aprotein from epidermal factor receptor, by examining RNA in samples onmobile and wearable screens, wherein it is therefore possible to tellwhat sorts of processes are going on inside a cell by seeking outfragments of tumor RNA in saliva, including those associated withcancer. Furthermore, wearable device may be integrated with one or morethin film silicon photonic biosensor that uses beams of light to detecttiny changes in the composition of a saliva or urine sample on thescreen of wearable device or mobile device, wherein which essentiallylooks at the level of binding between a DNA probe and target microRNA tofigure out the level of microRNA in the sample, wherein this may provideclues to the presence of some types of cancer, cardiac disease, andother serious health issues via artificial intelligence (AI) big dataanalysis. Biosensors designed to detect a specific biological analyte byessentially converting a biological entity (ie, protein, DNA, RNA) intoan electrical signal that can be detected and analyzed by using ofbiosensors in cancer detection and monitoring. The biosensors can bedesigned to detect emerging cancer biomarkers and to determine drugeffectiveness at various target sites. The biosensor may have thepotential to provide fast and accurate detection, reliable imaging ofcancer cells, and monitoring of angiogenesis and cancer metastasis, andthe ability to determine the effectiveness of anticancer chemotherapyagents. The method 500 may further include providing data associatedwith the one or more biometric parameters to be displayed on thedisplay. The one or more biometric parameters may include one or more ofthe following: a blood pressure, a heart rate, a glucose level, a bodytemperature, an environment temperature, and arterial properties.

The wearer may monitor CAR-T-cell therapy by separating the peripheralblood of the bearer patient immune T-cells in vitro sterile culture, andthen genetically engineered and modified, it is based on the type oftumor specificity of patients suffering from genetic modification and invitro expansion, and finally the wearer patient reinfusion body, achievethe purpose of killing tumor cells. The wearer may further monitorCAR-T-cell preparation, insert CAR molecular DNA be integrated intohuman chromosome 19 on the first intron AAVSl site, the donor DNAsequence provided in the CAR molecule containing a sequence upstream ofthe receptor sequences and AAVSl cut left arm sequence homology, CARdownstream molecule containing poly-A sequence and AAVSl the right armsequence homology. The wearer furthermore monitor gene edited T-cellsapplications to use the antibody molecules of various types of tumorsurface antigens into the application of human T-cell genome AAVSlsites. To avoid potential off-target effects, a mutant enzyme of Nickase Cas9 may be used to only cut off a strand of DNA, thesingle-stranded gap will promote homologous recombination, therefore, toinsert CAR molecules precisely integrated into human T-cell genomespecific “safe harbor” sites, which may not affect the function of anynormal human gene, avoiding the use of viral vectors security risks andexogenous gene transit may insert a series of fatal risk of genetictoxicity and immunogenicity of the genome, wherein may integrate varioustypes of tumor surface antigen receptor to human T-cell genome AAVSlsite express specific receptors for all types of tumor-specific T-cellsrecognize and kill tumor cells. The wearer may monitor a chimericantigen receptor (CAR) T-cells and a preparation method can allograft,aimed at resolving existing T-cell separation difficulties from patientown self, who cannot effectively kill tumor cells and mixed with theissue of tumor cells. Another kind T-cells can allograft chimeric T-cellantigen receptor, said chimeric T-cell antigen receptors includingT-cell receptors and a chimeric antigen, wherein the T-cell is agenetically engineered allogeneic transplantation can T-cells. Theallograft may be chimeric T-cell antigen receptor, wherein the T-cellsthrough gene knockout in a specific point of genetically modifiedT-cells. The allograft may be chimeric T-cell antigen receptor, whereinsaid specific gene of TCR gene, including the TCR [alpha] chain and a βchain, said genetically modified specifically: α in the TCR andcorresponding foreign gene encoding β-chain of one or two chain constantregion exon by gene knockout point, the TCR of T-cells is not active,and thus T-cells can be allogeneic. The allograft may be chimeric T-cellantigen receptor, wherein said chimeric antigen receptor by a scFvantigen binding sequence, a transmembrane sequence, and intracellularsignal transduction sequence. The allograft may be chimeric T-cellantigen receptor, wherein said scFv antigen binding sequence comprises alight chain variable region sequence and a heavy chain variable regionsequence. The allograft may be chimeric T-cell antigen receptor, whereinthe transmembrane sequence is CD8, wherein said intracellular signaltransduction sequence comprising the CD28 extracellular domain sequence,the sequence and the intracellular domain of 4-1BB intracellular CD3Gdomain sequences. A species, may allograft chimeric antigen receptorT-cells, which comprises of the TCR α and β chains of one or both chainsconstant outside the corresponding region of the gene coding exon, theT-cells TCR is not active, and then be able to obtain allogeneicT-cells, wherein furthermore carrying the chimeric receptor antigenlentivirus infection can be obtained by the above-described allogeneicT-cells can be obtained after completion of infection allogeneicchimeric T-cell antigen receptor. The wearer may monitor T-cellsgenetically engineered, in turn, can make this T-cell allografts withoutcausing immune rejection. Then this will not produce allograft immunerejection T-cell binding third-generation CAR can prepare an allograftuniversal chimeric antigen receptor T-cells to tumor therapy.

In an example embodiment, the method 500 may further include sensing arotational motion of the input unit. The input unit may be rotated bythe user. Based on the sensing, the data displayed on the display may bescrolled. Additionally, the method 500 may include activating avibration unit in response to receiving the data from the externaldevice to notify the user about receipt of the data.

FIG. 6 shows schematic representations of WPD devices 600 and 650,according to example embodiments. The WPD device 600 may include ahousing 202 that may enclose the elements of the WPD device 600 asdescribed above with reference to FIG. 2. The WPD device 600 may includea projector 610. The projector 610 may project a data onto a viewingsurface 620 to form a display area 630. The display area 630 may serveas a further display of the WPD device 600. The viewing surface 620 mayinclude a hand of the user. The data shown on the display area 630 mayinclude any data requested by the user or any incoming notifications oralerts, including a virtual keyboard, a notification of the externaldevice, time, data requested by the user, a caller name, a text message,a reminder, a social media alert, an email, a weather alert, and thelike. FIG. 6 shows a virtual keyboard 640 displayed on the hand of theuser.

The WPD device 650 may include a housing 202 that may enclose theelements of the WPD device 600 as described above with reference to FIG.2. The WPD device 650 may include a projector 660. The projector 660 mayproject a data onto a viewing surface 670 to form a display area 680.The display area 680 may serve as a further display of the WPD device650. The data shown on the display area 680 may include a message 690.

As shown on FIG. 6, the projector may be disposed on any side of thehousing 202. More specifically, the display area 630 may be provided tothe right from the wrist of the user (as in the WPD device 600) or thedisplay area 680 may be provided to the left from the wrist of the user(as in the WPD device 650).

FIG. 7 shows a man running and wearing various wearables with a sensor,e.g. smart glasses, smartwatch, etc. The sensor consists of a tri-axialaccelerometer, a microcontroller and a Bluetooth Low Energy transceiver.Cancer may be detected using Temperature Variation and RadiationAnalysis (TVRA) via wearable device, which has grown tangibly due tomany factors, such as at least life expectancies increase, personalhabits and ultraviolet radiation exposures. The smartwatch can displayvarious medical parameters received from the wearables and also displaydifferences between normal and cancerous cell structure.

FIG. 7 further shows the WPD device 750, which may be configured to berolled around a wrist of the user. The WPD device 750 may include aprocessor 755, a projector 760, activity tracking sensors 765, acommunication circuit including a Bluetooth module 770 or a Wi-Fi module775, a haptic touch control actuator 780, a memory unit 785, anindicator 790, such as a LED, and a charging unit 795.

FIG. 8 shows a mobile device 850 and smartwatch 800, which are wireconnected to a thin film silicon photonic biosensor 840. The biosensor840 may use beams of light to detect tiny changes in the composition ofa saliva or urine sample on a thin film 830. The film 830 when pressedagainst the skin may create changes in electrical current and light(ECL) that can be captured by a high-quality digital camera of awearable device. Normal and cancerous cell structures are displayed on ascreen of the mobile device 850 and smartwatch 800.

FIG. 9 shows a mobile device 900 which may be connected to a thin filmsilicon photonic biosensor 940 by wire or wirelessly.

FIGS. 10 and 11 show a point of healthcare (POH) saliva testing device1000 for POH saliva testing being a component of an artificialintelligence (AI) wearable and mobile personal digital device forfacilitating mobile device payments, personal saliva testing, personaluse, and health care, according to an example embodiment. The POH salivatesting device 1000 may be used together with the AI wearable and mobilepersonal digital device for facilitating mobile device payments,personal saliva testing, personal use, and health care, as shown on FIG.9. The POH saliva testing device 1000 may include a mounting clip 1005,a saliva sample insert apparatus 1010, a pinhole 1015, a light-emittingdiode (LED) board 1020, a battery 1025, and a set of sensors 1030.

FIG. 12 shows a right side view 1200 of the POH saliva testing device1000, a left side view 1210 of the POH saliva testing device 1000, afront view 1220 of the POH saliva testing device 1000, and a rear view1230 of the POH saliva testing device 1000, according to an exampleembodiment.

FIG. 13 shows a top view 1300 of the POH saliva testing device 1000 anda bottom view 1310 of the POH saliva testing device 1000, according toan example embodiment.

FIG. 14 shows a general view of an AI wearable and mobile personaldigital device 1400 with a POH saliva testing device 1000 for POH salivatesting. The POH saliva testing device 1000 may be attached using themounting clip 1005 to the AI wearable and mobile personal digital device1400. In an example embodiment, the POH saliva testing device 1000 maybe attached to a portion of the AI wearable and mobile personal digitaldevice 1400 where the camera of the AI wearable and mobile personaldigital device 1400 is disposed.

The processor AI wearable and mobile personal digital device 1400 may befurther configured to transmit the user request to one or more of theexternal device, the health care center, the hospital, the emergencycenter, the saliva research center, deoxyribonucleic acid (DNA) genetictesting and analysis authorities, and the like authorities.

FIG. 15A shows an example system 1500 for performing electroconvulsivetherapy (ECT). ECT is a procedure that may be done under generalanesthesia, in which small electric currents are passed through thebrain, intentionally triggering a brief seizure. ECT may cause changesin brain's chemical processes that can quickly reverse symptoms ofcertain mental illnesses. Operation of the system 1500 may require awell-trained operator. Usage of the system 1500 may be costly due tomaintenance services.

FIG. 15B shows a system 1550 for performing ECT, which may performfunctionality of the system 1500. However, in contrast to the system1500 the system 1550 may have compact size, and low electricityconsumption.

In some embodiments, the system 1550 includes a holder 1555 covering ahuman head. The holder 1555 may include built-in electrodes 1560. Theelectrodes 1560 may be connected to an AIWEM mobile device 1565 or AIWEMsmartwatch 1570 by a communication cable 1575. In some embodiments, thecommunication cable 1575 may include at least USB data cable. The mobiledevice 1565 or smartwatch 1570 may generate electric current shock waves1580 to kill early lesion and cancer cells or solid tumor and send themvia electrodes 1560 into a human brain.

FIG. 16 shows a new system for cancer treatment beyond conventionalsurgerial and radiation ones, according to an example embodiment. Themethod 1600 may include AI wearable electrowave medical (AIWEM) device,personal living T-cells drug (PLTCD) and organic tetranectin naturalnative proteins (OTNNP). The method 1600 for the cancer treatment mayinclude, in step 1, taking a blood sample from a user. In step 2, themethod 1600 may include extracting of the T-cells. The method 1600, instep 3, may include engineering of the T-cells. In step 4, the methodmay include administering of modified T-cells back to a patient. Themethod, in step 5, may include recognizing and killing of tumor by themodified T-cells. In step 6, the method 1600 may include generating theshock waves by the AIWEM smartwatch to enhance the process of killingthe tumor. In step 7, the method 1600 may include generating the shockwaves by the AIWEM mobile device to enhance the process of killing thetumor.

FIG. 17 shows the multistep process of tumorigenesis. Initiatingmutagenic events may convert single normal somatic cells to hyperplasticlesions. Cancer may evolve as a consequence of the selection of adiverse set of genetic drivers mutations, or progression events. Furthermutations may be required to achieve an advanced primary tumor that hasthe capability to metastasize. Events that endow cells with the abilityto leave the primary tumor site and seed new growths at distant sitesmay be metastatic events. These metastases may be found in the draininglymph node, adrenal glands, liver, pleural cavity, etc.

In an example embodiment, the WPD device 200, a mobile device 850, asmartwatch 800, and a mobile device 900 as described above may use Tcells for fighting infection. Telling the difference between a cancercell and a normal cell may be difficult for T cells. Therefore, thecancer cells may hide away and not be recognized. The wearable andmobile digital devices may give results.

Immunotherapy of adoptive cell transfer may work as a treatment forcancer by CAR T-cell therapy to collect and make a small change touser's T cells. Thereby target the cancer cells. White blood cellscalled lymphocytes may fight infection and diseases, including cancer. Tcells may move around the body to find and destroy defective cells. Whena human body comes into contact with a new infection or disease, thebody makes T cells to fight that specific infection or disease. Thehuman body keeps some T cells in reserve, so when the human body comesacross the infection again, the specific infection or disease may berecognized and attacked immediately.

CAR T-cell therapy may be performed in the following steps. First, put atube into a vein in each arm. One tube may remove the blood and pass itinto an apheresis machine. The machine may separate the different partsof the blood. For CAR T-cell therapy, the machine may take out the humanT cells. The rest of the human blood cells and normal blood fluid may goback into the human body through the tube in other arm. With wearabledigital device the T cells may be changed in a lab. The changed T cellsmay be called genetically engineered T cell. The T cell may become a CART-cell. CAR stands for chimeric antigen receptor. The CAR T-cells may beare designed to recognize and target a specific protein on the cancercells.

The changed T cells may grow and multiply in the lab. Once there areenough cells, the changed T cell may be returned into the human body'sbloodstream. The CAR T-cells may now recognize and attack the cancercells. The changed T cells may stay in your body for long periods oftime, recognizing and attacking the specific cancer cells.

In treatment for some leukaemias, CAR T-cells may be designed torecognize a protein called CD 19. The CD 19 may be found on the surfaceof most B cells. The B cells may be a type of white blood cell and, likeT cells, the B cells may play an important part in fighting theinfection. CAR T-cell therapy may target the CD 19 protein may alsodestroy the B cells. The CAR T-cell therapy may kill normal B cells aswell as cancerous B cells. The CAR T-cell therapy either may reduce thenumber of B cells or destroy them all. The CAR T-cell therapy may makeit difficult for the human body to fight infections.

The human body may need treatment for this side effect. This treatmentis called immunoglobulin therapy. The immunoglobulin therapy may containantibodies to help the human body in fighting the infection.

A deeper understanding of cancer immunology and technologicalimprovements in genomic sequencing and bioinformatics may advance thedevelopment of mRNA-based personalized cancer vaccines (PCVs). Thecustom-tailored vaccines may be designed based on each patient'sparticular tumor mutations (neoantigens), with the goal of inducinghigh-affinity immune T-cell responses against cancer. As malignanttumors may grow, genetic mutations may lead to the expression of uniquetumor antigens called “neoantigens,” which have emerged as a promisingtarget in oncology. In order to identify candidate neoantigens, DNA maybe extracted from an individual user's tumor cells and sequenced. Bycomparing the sequences of the user's tumor mutations with germline DNAfrom normal cells, the tumor mutations may be identified.

The neoantigens may be incorporated into mRNA. Subsequently, the mRNAmay be complexed with lipids to make an mRNA-lipoplex that may bedelivered intravenously. Upon administration, the mRNA-lipoplex maypreferentially localize to the spleen, where it may be taken up bydendritic cells. The mRNA may provide two critical components ofvaccines. The mRNA may serve as an adjuvant through stimulation of TLR7and TLR8, licensing dendritic cells to activate T cells. The mRNA mayalso be translated into a polypeptide. The polypeptide may be processedinto neoantigens. The neoantigens may be then loaded onto MHC moleculesand presented to T cells, inducing de novo generation and expansion ofpre-existing T cells that in turn may recognize and kill tumor cells.

Chimeric antigen receptor (CAR) T cell therapy is a powerful form ofimmunotherapy. Using this approach, immune cells may be taken from auser's bloodstream, reprogrammed to recognize and attack a specificprotein found in cancer cells, then reintroduced into the patient'ssystem, where the changed immune cells may destroy targeted tumor cells.The proprietary CAR T technology in active preclinical and clinicalprograms across a range of hematologic cancers and solid tumors.

The analysis may be conducted with memory T cells, a stem cell-likesubset of immune cells that remain in the human body after attacking thecancer. The T cells may then grow into an active reservoir ofcancer-killing cells capable of stopping future outbreaks. The CAR Tcell therapy may be a bridge to bone marrow transplant for leukemia andlymphoma patients. The diseases that may be targeted with CAR T cell areat least lymphoma, leukemia and glioblastoma, and with multiple myeloma,prostate cancer, liver cancer and breast cancer.

The human body's own stem cells may have the potential to regenerate allkind of cells of the body. Using the developed technology, the stemcells may be differentiated into neural cell, blood cells, skin cell andhair cells. These cells may be used to replace the old cells of bodywith new and young cells to treat the aging related diseases. Thetechnology may comprise isolating the maximum number of viable stemcells from adipose tissue as an autologous sources of user's own body totreat aging patients. B lymphocytes (B cells) may make antibodies tofight infection. T lymphocytes (T cells) may help B lymphocytes to makeantibodies to fight infection, and directly killing infected cells inthe human body. T lymphocytes may attack infected cells and eliminateviruses.

Immunotherapy treatment that utilizes the human body's own immune systemmay fight cancer and improve the human body's ability to detect and killcancer cells. Immune cells or antibodies may be produced under tightlycontrolled conditions and then given to patients to treat cancer. Thewearable and mobile devices testing results may help clinical trials todetermine their effectiveness in treating various types of cancer. Thetherapy first may require drawing blood from patients and separating outthe T cells. Next, using a disarmed virus, the T cells may begenetically engineered to produce receptors on their surface calledchimeric antigen receptors, or CARs. The receptors may comprisesynthetic molecules, which do not exist naturally. The special receptorsmay allow the T cells to recognize and attach to a specific protein, orantigen, on tumor cells. The CAR T cell therapies may furthest along indevelopment target an antigen found on B cells called CD19. Once thecollected T cells have been engineered to express the antigen-specificCAR, they may be “expanded” into the hundreds of millions. The finalstep may comprise the infusion of the CAR T cells into the patient whichis preceded by a “lymphodepleting” chemotherapy regimen, If all goes asplanned, the engineered cells may further multiply in the patient's bodyand, with guidance from their engineered receptor, recognize and killcancer cells that harbor the antigen on their surfaces.

In an example embodiment, the WPD device 200, a mobile device 850, asmartwatch 800, and a mobile device 900 as described above may beconfigured in a form of an AI wearable digital device for personalhealth use for saliva, urine, and blood testing. The AI wearable digitaldevice may be having a glucose metering unit configured to be attachedto the housing of the AI wearable digital device. The glucose meteringunit may be in communication with the processor. The glucose meteringunit may be configured to accommodate a test strip for receiving a bloodsample of the user. Upon insertion of the test strip having the bloodsample of the user into the glucose metering unit, the glucose meteringunit may measure a blood glucose level in the blood sample. The glucosemetering unit may further communicate the blood glucose level to theprocessor.

The AI wearable digital device may further include a disposable teststrip cartridge for test strips and a lancing device for cutting afinger to obtain a blood sample. The glucose metering unit may connectto the mobile device and automatically log blood glucose measurements ofthe user and sharing results of the user with caregivers and doctors.

Therefore, the glucose metering unit may act as an all-in-one smartglucose meter which includes a lancing device, a glucose meter, and teststrips, and is in communication with an application that automaticallyrecords blood glucose levels of the user to share blood glucose levelswith a doctor, builds charts, and determines statistics. The applicationmay further include a carbohydrate counting tool to count carbohydratecarbs consumed by the user to provide glucose management for the user.

In an example embodiment, the AI wearable digital device may furtherinclude an electrochemical detector configured to be attached to thehousing. The electrochemical detector may be in communication with theprocessor. The electrochemical detector may be configured to accommodatea sample, such as at least one of a blood sample, a urine sample, and asaliva sample of the user. Upon placing the sample into theelectrochemical detector, the electrochemical detector may apply apredetermined amount of an electric current to the sample. Upon applyingthe electric current, the electrochemical detector may measure a voltageand a current generated in liquids of the sample to determinecharacteristic signatures of the liquids in the sample. Based on thecharacteristic signatures, the electrochemical detector may analyze thesample to determine a red blood cell distribution width. Theelectrochemical detector may further determine a variation of a size ofred blood cells to predict development, progression, and risk a disease.The disease may include one of a cancer, a cardiovascular disease, HIV,and syphilis. The electrochemical detector may communicate dataassociated with the analysis to the processor.

More specifically, the AI wearable digital device may be configured toanalyze the sample of blood, urine and saliva to determine red bloodcell distribution width. Elevations in the extent of variation in thesize of red blood cells may be used for prediction of the development,progression, and risk of diseases, including cancer or cardiovasculardiseases.

The human body may slow down the production and destruction of red bloodcells in case of some diseases. The AI wearable digital device may beused to measure the production or destruction rates of the cells in thefluid samples to identify many of diseases in their earlier stages whenthe diseases are most treatable. Existing measures of the productionrate are far too imprecise to detect these changes in samples.

The electrochemical detector may measure the voltage or currentgenerated in liquids for characteristic signatures of the contents ofthe liquids in the samples. By applying electricity to a drop of thesample mixed with a reagent, the device can measure blood glucose levelsin the sample. Other measurements detected by the AI wearable digitaldevice may include heavy metals in water, malaria antigens in blood, andsodium in urine. Electrochemistry causes chemical reactions by passingthe electrical current through a solution of appropriate molecules. Themeasured blood glucose level glucose can be used in management ofdiabetes, serum electrolytes in diagnostic screening, chemiluminescentimmunoassays based on production of light.

The user may collect a drop of blood, urine or saliva into a cartridgewith several channels. Once the cartridge is inserted into theelectrochemical detector, the electrochemical detector may suck theblood into different channels and into a number of detection zones. Eachof the detection zones may be indicative of antibodies or antigenswithin the blood that may indicate the presence of a particular disease.

The electrochemical detector may be further configured to detectbiomarkers, including a prostate-specific antigen and a human chorionicgonadotropin hormone. The electrochemical detector may be furtherconfigured to perform electronic detection of microparticles. Thatallows biosensors to be shrunken to the size of a wearable band or amicro-chip to detect microorganisms, including disease-causing bacteriaand viruses.

In an example embodiment, the AI wearable digital device may furtherinclude a magnetic levitation unit insertable into the housing. Themagnetic levitation unit may be in communication with the processor. Themagnetic levitation unit may include a plurality of magnets forproducing a magnetic field and may be configured to, upon placing thesample into the magnetic levitation unit, separate cells in the sampleinto groups. The separation may be based on a type of the cells. Thegroups may include at least white blood cells and red blood cells. Themagnetic levitation unit may be further configured to communicate dataassociated with the separation to the processor. The processor may befurther configured to run computer imaging on a display of the device tovisualize the data associated with the separation and send the dataassociated with the separation to a third party.

In an example embodiment, the AI wearable digital device may be placedon top of a lens so that the camera of the AI wearable digital devicecan look down on tubes filled with finger-prick-size volumes of blood,urine or saliva. The fluid samples may be laced with a chemical, whichmay be paramagnetic and slightly attracted to magnetic fields. Thesesamples may be placed between two magnets. Cells may float up todifferent heights in the magnetic field depending on their density,which, in turn, may depends on their type. Therefore, the AI wearabledigital device may separate red and white blood cells of the sample.Thus, the AI wearable digital device may be used as a simple blood,urine and saliva testing device for anyone and anywhere. Themeasurements may be sent to the doctor to check on important markersindicating whether a treatment is working for the user. Furthermore, theAI wearable digital device may be useful beyond cancer monitoring,including determining if the user has a viral or bacterial infection andfor prediction of a cardiac arrest.

The use of anticoagulants has the effect of limiting the formation ofblood clots. However, this treatment requires frequent monitoring ofblood flow in the hospital. The AI wearable digital device may betransformed into a mini-laboratory by a single-use film, where thesmartphone and wearable devices may reveal an indication of coagulationwithin a short period of time. The film deposited on the device may bemade of a plastic layer. A drop of blood, urine or saliva may come intocontact with a molecule initiating the coagulation process. The AIwearable digital device may analyze disruptions in the electric field.This change of the electric field in the film may be analyzed. As thewrong dosage of anticoagulants can cause side effects, it is importantfor people who take them to be monitored to prevent any inappropriatetreatment. The AI wearable digital device may be used as self-monitoringdevices and may send measured data directly to the doctor.

In a further example embodiment, the AI wearable digital device may beconfigured in a form of a wrist watch to be worn by the user. The AIwearable digital device may further include a thermoelectric generator(TEG). The TEG may be configured to collect a heat of a body of theuser, convert the heat into energy, and store the energy in the battery.The battery may maintain the processor to store the medical information,time and fitness data when the user is not wearing the AI wearabledigital device.

Furthermore, the AI wearable digital device may further include a sensorconfigured to be in contact with a skin of the user and a wireconfigured to be placed under the skin of the user beneath the sensor toobtain a sample, such as at least a blood sample. The sensor may beconfigured to analyze the sample to determine at least a blood glucoselevel.

The TEG may include a first side (a hot side) and a second side (a coldside). The first side is a circular aluminum plate. The first side andthe second side may be separated from each other by an insulatingthermoplastic layer. The TEG may collect the heat flowing from thesecond side to the first side and turn the heat into an electricity.Therefore, the battery may be charged constantly whenever the user wearsthe AI wearable digital device.

In an example embodiment, the AI wearable digital device may beconfigured in a form of a waist belt having a TEG that senses body heatand converts it into energy. The TEG may be incorporated into clothes.The human body may be a constant heat source. Typically, a temperaturedifference exists between the body core and the environment. The TEG mayuse the temperature difference to generate electricity. Even if the userdoes not move and located in a dark place, the electricity still can beproduced. Lower ambient temperatures, air convection, or increasedactivity of the user increase the amount of the generated electricitywhen using a body heat as the source of energy.

In an example embodiment, the user may need to enter a PIN to verify theidentity of the user when making a purchase. The user may enter the PINby using a touch sensor of the AI wearable digital device. The AIwearable digital device may perform a payment upon approaching a cardreader automatically without opening a payment application. Pressing afinger to the sensor may verify the payment and medical information ofthe user. The AI wearable digital device may vibrate and produce a soundto let the user know that the payment is performed.

The TEG may generate electricity by using the temperature differentialbetween a body and the ambient air. The TEG may generates up to 20μW/cm2 without a heat sink. The TEG may include a layer of thermallyconductive material that may be attached to the skin and spread theheat. The conductive material may be topped with a polymer layer thatmay prevent the heat from dissipating to the ambient air. Heat that isnot converted into electricity passes through the TEG into an outerlayer of thermally conductive material, which dissipates the heat to theambient air.

The TEGs incorporated into T-shirts and other textile clothes may becapable of generating 8 μW/cm² up to 18 μW/cm² of heat depending on theactivity of the user. Therefore, the AI wearable digital device may beused for long-term health monitoring, such as to track heart health ormonitor physical and environmental variables to predict and preventdiseases of the user.

FIG. 18 is a schematic diagram 1800 of an AI wearable digital devicehaving a TEG, according to an example embodiment. Specifically, the AIwearable digital device 1805 may have a TEG 1805 located so as tocontact a body of the user when the user wears the AI wearable digitaldevice 1805. The TEG 1805 may collect the heat from the user body,convert the heat into the electricity, and provide the electricity to abattery of the TEG 1805. The TEG 1805 may be connected with the batteryvia a wire or wirelessly.

The processor may be further configured to encrypted measure data into athree-dimensional code based on three directions, i.e.length/up-to-bottom (X), width/right-to-left (Y), and height (Z). Thethree-dimensional code maybe created by layers of a two dimensional codeand allotment of additive colors of each layer.

Health and medical sensitive data and scanned images may be stored inthree-dimensional codes, four dimensional codes, five dimensional codes,and six dimensional codes.

FIG. 19 shows a schematic diagram 1900 of a heat-to-electricityconversion, according to an example embodiment. The TEG 1902 may collectheat 1904 from a body of the user and convert the heat 1904 intoelectricity 1906. The electricity 1906 is stored into a battery 1908.The TEG 1902 may further provide data related to eat-to-electricityconversion to a processor 1910 of the AI wearable digital device. Theelectricity 1906 stored in the battery 1908 may be used for powering theprocessor 1910 and other components of the AI wearable digital device.

Thus, various WPD devices for personal health use for saliva, urine, andblood testing and facilitating mobile device payments have beendescribed. Although embodiments have been described with reference tospecific example embodiments, it will be evident that variousmodifications and changes may be made to these embodiments withoutdeparting from the broader spirit and scope of the system and methoddescribed herein. Accordingly, the specification and drawings are to beregarded in an illustrative rather than a restrictive sense.

What is claimed is:
 1. A wearable digital device for adoptive celltransfer testing, the device comprising: a processor being operable to:receive data from an external device; based on the data, provide anotification to a user; receive a user input; perform a command, thecommand being selected based on the user input; provide a naturallanguage user interface to communicate with the user, the naturallanguage user interface being operable to sense a user voice and providea response in a natural language to the user; a near field communication(NFC) unit communicatively coupled to the processor; a displaycommunicatively coupled to the processor, the display including atouchscreen, wherein the display includes a force sensor, wherein theforce sensor is operable to sense a touch force applied by the user tothe display and calculate coordinates of a touch by the user, andfurther operable to analyze the touch force, and based on the touchforce, select a tap command or a press command based on a predeterminedcriteria; a memory unit communicatively coupled to the processor; acommunication circuit communicatively coupled to the processor andoperable to connect to a wireless network and communicate with theexternal device, calculating hourly health data and make related mobiledevices payments; a housing adapted to enclose at least the processor,the display, the one or more activity tracking sensors, the memory unit,and the communication circuit; an input unit communicatively coupled tothe processor, wherein the input unit extends from the housing and isconfigured to perform one or more of a rotational motion and a linearmotion, wherein the one or more motions are operable to input commandsto the processor; and a band adapted to attach to the housing and tosecure the device on a user body; biometric sensors disposed within theband and operable to sense one or more biometric parameters of the user,wherein based on detection that the one or more of the biometricparameters exceed predetermined limits, biometric sensors are configuredto produce the alarm, wherein the biometric sensors include lenses andinfrared light-emitting diodes (LED) and visible-light LEDs, wherein thebiometric sensors include a skin contact sensor data processing engine,the skin contact sensor data processing engine being operable to monitora user electrocardiogram and a heart rate of the user sensed by thebiometric sensors, the user electrocardiogram and the heart rate beingidentification and personal data of the user, wherein the skin contactsensor data processing engine is operable to prompt the user to enter apersonal identification number and associate the personal identificationnumber with both the user electrocardiogram and the heart rate obtainedafter the device has been secured to a wrist of the user, whereinprocessor stores the obtained electrocardiogram and heart rate in thememory unit as a reference electrocardiogram and reference heart rate; ahaptic touch control actuator operable to produce a haptic feedback inresponse to one or more events, the one or more events includingreceiving of the alert, receiving of a notification, a confirmation,movement of the device, receiving of the user input, and sensing of theone or more biometric parameters, the haptic feedback being sensed bythe user body, wherein the haptic feedback includes a plurality offeedback types, each of the one or more events being associated with oneof the plurality of feedback types; a set of electrodes with electricwires disposed within the band; a battery disposed in the housing of thedevice; a camera; a glucose metering unit configured to be attached tothe housing, the glucose metering unit being in communication with theprocessor, the glucose metering unit being configured to: accommodate atest strip for receiving a blood sample of the user; upon insertion ofthe test strip having the blood sample of the user into the glucosemetering unit, measure a blood glucose level in the blood sample; andcommunicate the blood glucose level to the processor; an electrochemicaldetector configured to be attached to the housing, the electrochemicaldetector being in communication with the processor, the electrochemicaldetector being configured to: accommodate a sample, the sample includingat least one of a blood sample, a urine sample, and a saliva sample ofthe user; upon placing the sample into the electrochemical detector,apply a predetermined amount of an electric current to the sample; uponapplying the electric current, measure a voltage and a current generatedin liquids of the sample to determine characteristic signatures of theliquids in the sample, based on the characteristic signatures, analyzethe sample to determine a red blood cell distribution width and avariation of a size of red blood cells to estimate effectiveness of Tcells impact in CAR T-cell therapy of a disease used during the adoptivecell transfer, the disease including one of a cancer and acardiovascular disease; and communicate data associated with theanalysis to the processor, wherein the device in configured in a form ofa wrist watch to be worn by the user, wherein the device furtherincludes: a thermoelectric generator (TEG) configured to: collect a heatof a body of the user; convert the heat into energy; and store theenergy in the batter; a sensor configured to be in contact with a skinof the user; and a wire configured to be placed under the skin of theuser beneath the sensor to obtain a sample, the sample including atleast a blood sample, wherein the sensor is configured to analyze thesample to determine at least a blood glucose level.
 2. The system ofclaim 1, wherein the T cells fight infection and the wearable digitaldevice for adoptive cell transfer testing may aid the T cell torecognize a cancer cell and a normal cell.
 3. The system of claim 1,wherein the therapy of the adoptive cell transfer works as a treatmentfor cancer by CAR T-cell therapy to collect and make a small change touser's T cells and then target the cancer cells.
 4. The system of claim1, wherein the T cells fight infection and diseases, including cancer,wherein the T cells move around the body to find and destroy defectivecells, wherein the body makes the T cells to fight the specificinfection or disease, wherein the body keeps some T cells in reservethat the T cells recognize the disease and attack it immediately whenthe infection comes across the body again.
 5. The system of claim 1,wherein the CAR T-cell therapy includes: inserting a tube into a vein ineach arm; removing, by one tube, the blood; passing the blood into anapheresis machine; separating, by the machine, the different parts ofthe blood, including the T cells; and returning rest of the blood cellsand normal blood fluid back into the body through the tube in the otherarm.
 6. The system of claim 1, wherein the CAR T-cell therapy includes:sampling the blood; extracting the T-cells; engineering the T-cells;administering the T-cells back to a patient; recognizing modifiedT-cells to kill tumor; and showing results on a Point of Healthcare(POH) watch or Point of Healthcare (POH) mobile device.
 7. The system ofclaim 1, wherein the wearable digital device changes the T cells in alab, the changing comprises genetically engineering of the T cell,wherein the T cell becomes the CAR T-cell, wherein the CAR stands forchimeric antigen receptor, wherein the CAR T-cells are designed torecognize and target a specific protein on the cancer cells.
 8. Thesystem of claim 1, wherein the changed T cells grow and multiply in thelab, wherein the changed T cells are returned back into user'sbloodstream once there are enough of the T cells, wherein the aim forthe T cells is to recognize and attack the cancer cells, wherein the Tcells changed in the lab can stay in the body for long periods of timeto recognize and attack the specific cancer cells.
 9. The system ofclaim 1, wherein the disease includes leukemia, wherein the CAR T-cellsare designed to recognize a protein called CD 19, wherein the CD 19 isfound on the surface of B cells, wherein the B cells are a type of whiteblood cell, wherein the B cells play an important part in fightinginfection, wherein the CAR T-cell therapy targets the CD 19 protein anddestroys the B cells, wherein the CAR T-cell kills normal B cells aswell as cancerous B cells, wherein the CAR T-cell therapy eitherdestroys or reduces the number of B cells, wherein a treatment for theside effect is needed, wherein the treatment is called immunoglobulintherapy, wherein the immunoglobulin therapy contains antibodies to helpin fighting the infection.
 10. The system of claim 1, wherein thetherapy of the adoptive cell transfer includes mRNA-based personalizedcancer vaccines, the wherein personalized cancer vaccines are designedbased on each patient's particular tumor mutations (neoantigens), withthe goal of inducing high-affinity immune T-cell responses againstcancer, wherein the tumors grow and genetic mutations lead to theexpression of unique tumor antigens called “neoantigens,” which haveemerged as a promising target in oncology, wherein DNA is extracted froman individual user's tumor cells and sequenced in order to identifycandidate neoantigen, wherein tumor mutations are identified bycomparing the sequences of the user's tumor mutations with germline DNAfrom normal cells.
 11. The system of claim 1, wherein the therapy of theadoptive cell transfer includes mRNA-based personalized cancer vaccines,the wherein personalized cancer vaccines are designed based on eachpatient's particular tumor mutations (neoantigens), wherein theneoantigens are incorporated into mRNA, the mRNA is complexed withlipids to make an mRNA-lipoplex that can be delivered intravenously,wherein upon administration, the mRNA-lipoplex preferentially localizesto the spleen, wherein the mRNA-lipoplex is taken up by dendritic cells,wherein the mRNA provides two critical components of vaccines, whereinmRNA-lipoplex serves as an adjuvant through stimulation of TLR7 andTLR8, licensing dendritic cells to activate T cells, wherein the mRNA isalso translated into a polypeptide that is processed into neoantigens,wherein the neoantigens are then loaded onto MHC molecules and presentedto T cells, inducing de novo generation and expansion of pre-existing Tcells that in turn can recognize and kill tumor cells.
 12. The system ofclaim 1, wherein the CAR T-cell therapy is a powerful form ofimmunotherapy known as chimeric antigen receptor (CAR) T cell therapy,wherein the CAR T-cell therapy includes: extracting immune cells from auser's bloodstream; reprogramming to recognize and attack a specificprotein found in cancer cells; and reintroducing the immune cells intothe patient's blood system, wherein the immune cells destroy targetedtumor cells, wherein proprietary CAR T technology is used in activepreclinical and clinical programs across a range of hematologic cancersand solid tumors.
 13. The system of claim 1, wherein the CAR T-celltherapy is conducted with memory T cells, the memory T cells are a stemcell-like subset of immune cells that remain in user's body afterattacking the cancer, wherein the memory T cells grow into an activereservoir of cancer-killing cells capable of stopping future outbreaks,wherein the CAR T cell therapy comprises a bridge to bone marrowtransplant for leukemia and lymphoma patients.
 14. The system of claim1, wherein the disease includes lymphoma, leukemia and glioblastoma, andwith multiple myeloma, prostate cancer, liver cancer and breast cancer.15. The system of claim 1, wherein the CAR T-cell therapy includesuser's own stem cells, the stem cells have the potential to regenerateall kind of cells of the body, wherein the stem cells differentiate intoneural cells, blood cells, skin cells and hair cells, wherein the stemcells are used to replace the old cells of body with new and young cellsto treat the aging related diseases, wherein the maximum number ofviable stem cells are isolated from adipose tissue as an autologoussources of user's own body to treat aging patients.
 16. The system ofclaim 1, wherein the CAR T-cell therapy includes a lymphoid stem cell,the lymphoid stem cell becomes a lymphoblast cell and then one of threetypes of lymphocytes (white blood cells), which comprise: B lymphocytesthat make antibodies to help fight infection; T lymphocytes that helpthe B lymphocytes make antibodies to fight infection; and natural killercells that attack cancer cells and viruses.
 17. The system of claim 1,wherein the CAR T-cell therapy includes immunotherapy treatment thatutilizes the body's own immune system to fight cancer and improves thebody's ability to detect and kill cancer cells, wherein the immune cellsor antibodies produced in the lab under tightly controlled conditionsand given to patients to treat cancer, wherein wearable and mobiledevices testing results help clinical trials to determine effectivenessin treating various types of cancer.
 18. The system of claim 1, whereinthe CAR T-cell therapy includes: drawing blood from patient; separatingout the T cells; genetically engineering the T cells, by a disarmedvirus, to produce receptors on the T cells surface called chimericantigen receptors or CARs, wherein the receptors are synthetic moleculesthat do not exist naturally, wherein the receptors allow the T cells torecognize and attach to a specific protein, or antigen, on tumor cells,wherein the CAR T cell therapy targets an antigen found on B cellscalled CD19; expanding the engineered T cells into the hundreds ofmillions in the lab to express the antigen-specific CAR; infusing of theCAR T cells into the patient which is preceded by a “lymphodepleting”chemotherapy regimen; multiplying of the engineered T cells in thepatient's body; and with guidance from their engineered receptor,recognizing and killing cancer cells that harbor the antigen on theirsurfaces.
 19. The system of claim 1, wherein the camera is operable to:track a face, fingers, and gestures; and the processor is furtheroperable to: analyze the face, the fingers, the gestures, and a humanbody tracked by the camera; wherein the camera is further operable toperform an optical character recognition of a data, the data processingincluding one or more of the following: a typewritten text, a printedtext, and an image, the data being scanned from a document, the documentincluding one or more of the following: a passport, an invoice, a bankstatement, a computerized receipt, a business card, a mail, a printoutof static-data, a book, and a print publication; wherein the display isoperable to be activated based on one or more of the following: amovement of a user hand, a movement of the user body, a gestureperformed by the user in proximity to the display, and a user voice. 20.The system of claim 1, further comprising: a microphone operable to:sense voice data, the voice data being obtained from the user andincluding a voice command, a voice memo, or a voice message; andtransmit the voice data and personal health data to the processor; and alight indicator being operable to show a light indication in response toreceiving the data from an external device, wherein upon a predeterminedmovement of the user body the light indication stops showing the lightindication and initiates the display to display the data received fromthe external device.